Precision BioSciences Presents Late-Breaking Phase 1 PBGENE-HBV Data at AASLD The Liver ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

LDL Cholesterol Improved Among Veterans in Program With Health Coaches, Other Resources

After 24 months, 34% of veterans who have heart and blood vessel disease and high cholesterol in a quality improvement ...